A Comparative Study of Lansoprazole and Mosapride for Functional Dyspepsia: Focus on Difference Between Epigastric Pain Syndrome and Postprandial Distress Syndrome.

Trial Profile

A Comparative Study of Lansoprazole and Mosapride for Functional Dyspepsia: Focus on Difference Between Epigastric Pain Syndrome and Postprandial Distress Syndrome.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2011

At a glance

  • Drugs Lansoprazole (Primary) ; Mosapride (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 May 2010 Results have been presented at Digestive Disease Week (DDW) 2010.
    • 14 Oct 2009 Actual patient number (329) added as reported by ClinicalTrials.gov.
    • 14 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top